Ftse Mib
36.059,17
-0,23%
DAX
21.042,00
0,18%
S&P 500
6.049,24
0,88%
NASDAQ
19.756,78
0,64%
Bitcoin
105.686,68
-0,45%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Eton Pharmaceuticals Inc (ETON) Eton Pharmaceuticals Inc (ETON) Notizie

Eton Pharmaceuticals Inc

ETON
14,44
0,03 (0,21%)
22 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/1/202522:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202513:05EDGAR2Form 8-K - Current report
03/1/202512:50GLOBEEton Pharmaceuticals Advances Its Commitment to Rare Disease..
20/12/202413:05EDGAR2Form 8-K - Current report
20/12/202412:50GLOBEEton Pharmaceuticals Closes Acquisition of Increlex®..
17/12/202413:05EDGAR2Form 8-K - Current report
17/12/202412:50GLOBEEton Pharmaceuticals Announces Final Readout of PKU GOLIKE®..
12/12/202422:30EDGAR2Form 8-K - Current report
12/12/202422:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/12/202423:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/12/202413:00EDGAR2Form 8-K - Current report
03/12/202412:50GLOBEEton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief..
25/11/202413:00EDGAR2Form 8-K - Current report
25/11/202412:50GLOBEEton Pharmaceuticals Announces Acquisition of U.S. Rights to..
12/11/202422:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:15EDGAR2Form 8-K - Current report
12/11/202422:01GLOBEEton Pharmaceuticals Reports Third Quarter 2024 Financial..
07/11/202413:05EDGAR2Form 8-K - Current report
07/11/202413:00GLOBEEton Pharmaceuticals Awarded Second Patent for ET-400..
06/11/202422:30GLOBEEton Pharmaceuticals to Report Third Quarter 2024 Financial..
04/10/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202412:30EDGAR2Form 8-K - Current report
03/10/202412:30GLOBEEton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin..
22/8/202422:30GLOBEEton Pharmaceuticals to Participate at the H.C. Wainwright..
08/8/202422:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:21EDGAR2Form 8-K - Current report
08/8/202422:01GLOBEEton Pharmaceuticals Reports Second Quarter 2024 Financial..
02/8/202422:16EDGAR2Form 8-K/A - Current report: [Amend]
30/7/202423:30GLOBEEton Pharmaceuticals to Report Second Quarter 2024 Financial..
15/7/202422:16EDGAR2Form 8-K - Current report
15/7/202422:05GLOBEEton Pharmaceuticals Announces FDA Acceptance of New Drug..
11/6/202422:18EDGAR2Form 8-K - Current report
09/5/202422:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:17EDGAR2Form 8-K - Current report
09/5/202422:01GLOBEEton Pharmaceuticals Reports First Quarter 2024 Financial..
01/5/202422:05GLOBEEton Pharmaceuticals to Present at the Citizens JMP Life..
30/4/202413:00GLOBEEton Pharmaceuticals Announces Submission to FDA of New Drug..
29/4/202422:30GLOBEEton Pharmaceuticals to Report First Quarter 2024 Financial..
22/3/202407:00GLOBEEton Pharmaceuticals Announces Acquisition of PKU GOLIKE®..
14/3/202421:01GLOBEEton Pharmaceuticals Reports Fourth Quarter and Full Year..
29/2/202422:01GLOBEEton Pharmaceuticals to Report Fourth Quarter and Full Year..
21/2/202412:55EDGAR2Form 8-K - Current report
21/2/202412:50GLOBEEton Pharmaceuticals Awarded U.S. Patent for Proprietary..
15/2/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202412:55EDGAR2Form 8-K - Current report
02/2/202412:50GLOBEEton Pharmaceuticals Announces Commercial Availability of..
Apertura: 14,46 Min: 14,46 Max: 15,706
Chiusura: 14,41

La tua Cronologia

NASDAQ
ETON
Eton Pharmaceuticals
BIT
LCUS
Lyxor Core Us Equity Dr ...
BOV
KLBN3R
KLABIN ON
EU
ALAMG
Auplata Mining
BIT
P1DQ66
BNP Paribas Issuance
EU
CA10L
CAC 40 X10 Leverage Net ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network